Morgan Stanley Maintains Equal-Weight on Incyte, Lowers Price Target to $83

Morgan Stanley analyst Matthew Harrison maintains Incyte (NASDAQ:INCY) with a Equal-Weight and lowers the price target from $89 to $83.

Benzinga · 01/06/2020 14:13

Morgan Stanley analyst Matthew Harrison maintains Incyte (NASDAQ:INCY) with a Equal-Weight and lowers the price target from $89 to $83.